Lenz Therapeutics Inc (LENZ) Stock Price, Quote & News

Company Profile

LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, Cal...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 925 7000

Website: www.lenz-tx.com

Address:

201 Lomas Santa Fe Drive, Suite 300, Solana Beach, United States

LiquidThetaLEAPS Oct. 4 at 9:31 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $LENZ Current Share Price: $48.74 Contracts: $LENZ January 15, 2027 $50 Calls Scale in: $15.25- $18.64 Scale out: $23.73-$30.51 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

Paddy444 Oct. 3 at 7:15 PM

$LENZ $APLD $UAMY etc etc etc in my portfolio- work right.. and why would I need to sell my brains and work ethic.. I'm already doing well. Are they? are you? I hope more and more stay away from the weee queens and other sellers and understand they can work right on there own. Bonfire crackling, nectar flowing.. just feeling right from working right See ya 444

0 · Reply

Vikingsstrade Oct. 3 at 4:42 PM

$SEPN $CNTX $LITM $LENZ Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.

0 · Reply

GamBino_MaF187 Oct. 3 at 3:41 PM

$LENZ

0 · Reply

walkersinc Oct. 3 at 1:46 PM

$LENZ Any laboratory capable of these results is worth way more than 1 billion market cap. Just think about all the speculative companies worth 10 plus billion with no product on the table, just a CEO that can sell water to a well.

0 · Reply

shkspr Oct. 3 at 3:09 AM

$LENZ If you’re interested in learning to trade the way I do, sign up here http://Www.redteam.us

1 · Reply

Paddy444 Oct. 2 at 8:36 PM

$LENZ if integrity, heart, character, love for the kind, more heart, effort, more effort, working right and feeling good about that If you have put all that in and understand the magnitude here finding solidified substance of need and want globally.. Well grab a fire, nectar, and really embrace this.. or don't https://www.youtube.com/watch?v=xtt0XwInYDM&list=PLW_7uScAuuyEOJKNHOKRIk3l_9LKMiGOY&index=5

0 · Reply

LiquidThetaLEAPS Oct. 2 at 7:20 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $LENZ Current Share Price: $49.05 Contracts: $LENZ January 15, 2027 $50 Calls Scale in: $15.26- $18.65 Scale out: $23.73-$30.51 Can Easily Capture: 60% ROI Blended DTE: 471 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

Paddy444 Oct. 2 at 4:11 PM

$LENZ Well, this month is really going to get many of the real to the table. I have already digested everything, the masses are getting ready to sit down in a way, well, a lot bigger than most fathom. Its ok, ask Norm Stay cool and kind, work right 444

0 · Reply

GamBino_MaF187 Oct. 2 at 3:46 PM

$LENZ

0 · Reply

LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States

Sep 30, 2025, 8:00 AM EDT - 4 days ago

LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States

Sep 10, 2025, 3:05 PM EDT - 24 days ago

LENZ Therapeutics, Inc. (LENZ) Therapeutics, Inc. Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 3, 2025, 2:49 PM EDT - 4 weeks ago

LENZ Therapeutics, Inc. (LENZ) Therapeutics, Inc. Presents At Citi's Biopharma Back To School Conference Transcript

Aug 25, 2025, 8:00 AM EDT - 5 weeks ago

LENZ Therapeutics to Present at Upcoming Investor and Medical Conferences

Jul 31, 2025, 4:05 PM EDT - 2 months ago

LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia

Jul 30, 2025, 8:00 AM EDT - 2 months ago

LENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Jul 29, 2025, 1:32 PM EDT - 2 months ago

LENZ Therapeutics: Undervalued Ahead Of PDUFA

Jul 28, 2025, 8:00 AM EDT - 2 months ago

LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia

Jul 7, 2025, 8:00 AM EDT - 3 months ago

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada

Jul 1, 2025, 4:23 PM EDT - 3 months ago

LENZ Therapeutics: Presbyopia Eyedrops Look Promising

May 27, 2025, 8:00 AM EDT - 4 months ago

LENZ Therapeutics to Present at Upcoming Investor Conferences

May 9, 2025, 10:33 AM EDT - 5 months ago

LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript

May 9, 2025, 9:03 AM EDT - 5 months ago

LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia

May 7, 2025, 4:05 PM EDT - 5 months ago

LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 6, 2025, 4:30 PM EDT - 5 months ago

LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference

Apr 30, 2025, 4:30 PM EDT - 5 months ago

LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025

Apr 7, 2025, 8:00 AM EDT - 6 months ago

LENZ Therapeutics: Freedom From Reading Glasses

Mar 27, 2025, 5:33 PM EDT - 6 months ago

LENZ Therapeutics Stock Is Attractive Before PDUFA

Mar 19, 2025, 8:09 PM EDT - 7 months ago

LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 4:05 PM EDT - 7 months ago

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 11, 2025, 8:00 AM EDT - 7 months ago

LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025

Mar 3, 2025, 8:00 AM EST - 7 months ago

LENZ Therapeutics to Host Commercial Day on April 15, 2025

Feb 24, 2025, 8:00 AM EST - 7 months ago

LENZ Therapeutics to Participate in Upcoming Investor Conferences

Nov 6, 2024, 11:43 AM EST - 11 months ago

LENZ Therapeutics, Inc. (LENZ) Q3 2024 Earnings Call Transcript

Oct 28, 2024, 1:51 PM EDT - 1 year ago

LENZ Therapeutics' Investigational Drug For Age-Related Blindness Aces Pivotal China Trial, Analyst Says Data Readout May Strengthen Position For Ex-U.S. Partnerships

Oct 27, 2024, 9:00 PM EDT - 1 year ago

CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100

Oct 21, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

ABOS

Aug 30, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks

Aug 16, 2024, 7:43 PM EDT - 1 year ago

LENZ Therapeutics, Inc. (LENZ) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:05 PM EDT - 1 year ago

LENZ Therapeutics Reports Second Quarter 2024 Financial Results

Aug 12, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia

Aug 7, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024

Jun 10, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024

May 30, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference

May 11, 2024, 7:26 AM EDT - 1 year ago

LENZ Therapeutics, Inc. (LENZ) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 1, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024

Apr 3, 2024, 7:49 AM EDT - 1 year ago

Lenz Therapeutics' eye disease drugs meet main goal of late-stage study

Apr 3, 2024, 7:00 AM EDT - 1 year ago

LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials

Apr 2, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia Trials

Mar 21, 2024, 4:30 PM EDT - 1 year ago

LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress

LiquidThetaLEAPS Oct. 4 at 9:31 PM

0 · Reply

Paddy444 Oct. 3 at 7:15 PM

0 · Reply

Vikingsstrade Oct. 3 at 4:42 PM

0 · Reply

GamBino_MaF187 Oct. 3 at 3:41 PM

$LENZ

0 · Reply

walkersinc Oct. 3 at 1:46 PM

0 · Reply

shkspr Oct. 3 at 3:09 AM

$LENZ If you’re interested in learning to trade the way I do, sign up here http://Www.redteam.us

1 · Reply

Paddy444 Oct. 2 at 8:36 PM

0 · Reply

LiquidThetaLEAPS Oct. 2 at 7:20 PM

0 · Reply

Paddy444 Oct. 2 at 4:11 PM

0 · Reply

GamBino_MaF187 Oct. 2 at 3:46 PM

$LENZ

0 · Reply

GamBino_MaF187 Oct. 2 at 1:30 PM

$LENZ LETS GO !!!

0 · Reply

AnotherRandomDude Oct. 2 at 8:59 AM

$LENZ Where’s ol @Paddy444 , did he not make it back from the bonfire ? Most hear but don’t listen, who doesn’t love a fresh pair of socks

1 · Reply

FeatherWeight Oct. 2 at 4:20 AM

$LENZ buyout for $10BILLION?!? On the premise that Xiidra (eye drop for dry eye disease; DED) got bought twice, once in 2019 for 5.3Billion and then in 2023 for 2.5Billion. The number of people who are affected by presbyopia is much larger than by DED…. basically a universal market, everyone ages. Late-night wishful thinking lol 🛌💭💤

0 · Reply

Optiongenius Oct. 2 at 12:22 AM

$LENZ CANT U SEE LENZ IS THE NEW VIAGRA 10/17 $50 calls

0 · Reply

GamBino_MaF187 Oct. 1 at 7:54 PM

$LENZ

0 · Reply

GamBino_MaF187 Oct. 1 at 4:05 PM

$LENZ I'LL POUND THE TABLE ON THIS EVERYDAY .... ADD & HOLD

0 · Reply

GamBino_MaF187 Oct. 1 at 4:02 PM

$LENZ

0 · Reply

Rmccall Oct. 1 at 2:37 PM

$LLY the next blockbuster is $LENZ. The TAM is bigger than that of GLPs!!! Look it up.

0 · Reply

Rmccall Oct. 1 at 2:21 PM

$LENZ we are still in the very early innings on this one!!! Everyone can "SEE" that!!! Yes a pun!

0 · Reply

Stockwolfie Oct. 1 at 2:17 PM

$LENZ don’t own, wish I did this will be a block buster but I think I Missed the initial run

1 · Reply

GamBino_MaF187 Oct. 1 at 1:15 PM

$LENZ MASSIVE OPPORTUNITY HERE . THE VIZZ WILL BE A BLOCKBUSTER . 100 + DOLLAR STOCK

1 · Reply

GamBino_MaF187 Sep. 30 at 4:38 PM

$LENZ

0 · Reply

Market Cap	1.38B
Revenue (ttm)	0.00
Net Income (ttm)	-49.77M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	327,600
Avg Vol	544,692
Day's Range	N/A - N/A
Shares Out	28.52M
Stochastic %K	85%
Beta	0.50
Analysts	Strong Sell
Price Target	$49.71